NervGen Pharma Valuation
| NGENF Stock | USD 4.29 0.13 3.12% |
At this time, the firm appears to be overvalued. NervGen Pharma Corp secures a last-minute Real Value of $3.53 per share. The latest price of the firm is $4.29. Our model forecasts the value of NervGen Pharma Corp from analyzing the firm fundamentals such as Current Valuation of 48.78 M, return on equity of -1.42, and Shares Owned By Insiders of 25.27 % as well as examining its technical indicators and probability of bankruptcy. . In general, most investors recommend locking in undervalued stocks and disposing overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that NervGen Pharma's price fluctuation is risky at this time. Calculation of the real value of NervGen Pharma Corp is based on 3 months time horizon. Increasing NervGen Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the NervGen otc stock is determined by what a typical buyer is willing to pay for full or partial control of NervGen Pharma Corp. Since NervGen Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NervGen OTC Stock. However, NervGen Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.29 | Real 3.53 | Hype 4.16 | Naive 5.11 |
The real value of NervGen OTC Stock, also known as its intrinsic value, is the underlying worth of NervGen Pharma Corp OTC Stock, which is reflected in its stock price. It is based on NervGen Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of NervGen Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of NervGen Pharma Corp helps investors to forecast how NervGen otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NervGen Pharma more accurately as focusing exclusively on NervGen Pharma's fundamentals will not take into account other important factors: About NervGen Pharma Valuation
The otc valuation mechanism determines NervGen Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of NervGen Pharma. We calculate exposure to NervGen Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of NervGen Pharma's related companies.NervGen Pharma Corp., together with its subsidiaries, engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage. NervGen Pharma Corp. was incorporated in 2017 and is based in Vancouver, Canada. NERVGEN PHARMA operates under Biotechnology classification in the United States and is traded on OTC Exchange.
8 Steps to conduct NervGen Pharma's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates NervGen Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct NervGen Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain NervGen Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine NervGen Pharma's revenue streams: Identify NervGen Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research NervGen Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish NervGen Pharma's growth potential: Evaluate NervGen Pharma's management, business model, and growth potential.
- Determine NervGen Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate NervGen Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
NervGen Pharma Growth Indicators
Investing in growth stocks can be very risky. If the company such as NervGen Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 46.2 M | |
| Retained Earnings | -35 M |
Complementary Tools for NervGen OTC Stock analysis
When running NervGen Pharma's price analysis, check to measure NervGen Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NervGen Pharma is operating at the current time. Most of NervGen Pharma's value examination focuses on studying past and present price action to predict the probability of NervGen Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NervGen Pharma's price. Additionally, you may evaluate how the addition of NervGen Pharma to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |